Βιβλιογραφία

  1. Blobner M, Eriksson LI, Scholz J, et al. Reversal of rocuronium-induced neuromuscular blockade the sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol. 2010;27(10):874–881.
  2. Jones RK, Caldwell JE, Brull SJ, et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816–824.
  3. Mencke T, Echternach M, Kleinschmidt S, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003; 98(5): 1049-1056
  4. Welliver M, McDonough J, Kalynych N, et al. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent. Drug Des Devel Ther. 2008; 2:49–59.
  5. Ogunnaike BO, Jones SB, Jones DB, et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95(6):1793–1805.
  6. Matsuzaki S. Jardon K. et al Impact of intraperitoneal pressure of a CO2 pneumoperitoneum on the surgical peritoneal environment. Human Reproduction 27,(6) 1613-1623 ,2012
  7. Lemmens HJM, El-Orbany MI, Berry J, et al. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine. BMC Anesthesiol. 2010;10(1):15.
  8. Turner JM. Some general considerations in neuroanaesthesia. In: Matta BF, Menon DK, Turner JM, eds.Textbook of Neuroanaesthesia and Critical Care. London, England: Greenwich Medical Media Ltd; 2000:171–179.
  9. Bridion [Summary of Product Characteristics], MSD, 2014
  10. Esmeron [Summary of Product Characteristics], MSD, 2014
  11. Harris AM, Welliver M, Redfern R, et al. Orthopaedic surgery implications of a novel encapsulation process that improves neuromuscular blockade and reversal. Internet Orthop Surg. 2007;7(2).